MX2009004096A - Metabolitos de talarozol. - Google Patents
Metabolitos de talarozol.Info
- Publication number
- MX2009004096A MX2009004096A MX2009004096A MX2009004096A MX2009004096A MX 2009004096 A MX2009004096 A MX 2009004096A MX 2009004096 A MX2009004096 A MX 2009004096A MX 2009004096 A MX2009004096 A MX 2009004096A MX 2009004096 A MX2009004096 A MX 2009004096A
- Authority
- MX
- Mexico
- Prior art keywords
- talarazole
- metabolites
- gly
- oso3h
- glucuronate
- Prior art date
Links
- 239000002207 metabolite Substances 0.000 title abstract 2
- 229910004727 OSO3H Inorganic materials 0.000 abstract 2
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940097042 glucuronate Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85198906P | 2006-10-17 | 2006-10-17 | |
| PCT/US2007/081685 WO2008049027A1 (en) | 2006-10-17 | 2007-10-17 | Talarazole metabolites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009004096A true MX2009004096A (es) | 2009-06-16 |
Family
ID=39314359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009004096A MX2009004096A (es) | 2006-10-17 | 2007-10-17 | Metabolitos de talarozol. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8188124B2 (enExample) |
| EP (1) | EP2114895A4 (enExample) |
| JP (1) | JP5343267B2 (enExample) |
| KR (1) | KR101419965B1 (enExample) |
| CN (1) | CN101611016B (enExample) |
| AU (1) | AU2007311026B2 (enExample) |
| BR (1) | BRPI0718310A2 (enExample) |
| CA (1) | CA2667053C (enExample) |
| MX (1) | MX2009004096A (enExample) |
| WO (1) | WO2008049027A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9080145B2 (en) | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
| RU2473685C2 (ru) | 2007-07-31 | 2013-01-27 | Лайфскен, Инк. | Дифференцировка человеческих эмбриональных стволовых клеток |
| CN107574142B (zh) | 2007-11-27 | 2021-07-06 | 生命扫描有限公司 | 人胚胎干细胞的分化 |
| BRPI0908033A2 (pt) | 2008-02-21 | 2015-08-04 | Centocor Ortho Biotech Inc | Método placas de superfície modificada e composições para adesão, cultura e desprendimento de célula |
| CA2729121C (en) | 2008-06-30 | 2019-04-09 | Centocor Ortho Biotech Inc. | Differentiation of pluripotent stem cells |
| JP2012507289A (ja) | 2008-10-31 | 2012-03-29 | ヤンセン バイオテツク，インコーポレーテツド | ヒト胚性幹細胞の膵内分泌系への分化 |
| EP2346988B1 (en) | 2008-10-31 | 2017-05-31 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
| MX2011005288A (es) | 2008-11-20 | 2011-06-01 | Centocor Ortho Biotech Inc | Celulas madre pluripotentes en microportadores. |
| CA2744227C (en) | 2008-11-20 | 2018-10-02 | Centocor Ortho Biotech Inc. | Methods and compositions for cell attachment and cultivation on planar substrates |
| EP2456862A4 (en) | 2009-07-20 | 2013-02-27 | Janssen Biotech Inc | DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS |
| DK2516625T3 (da) | 2009-12-23 | 2024-09-09 | Janssen Biotech Inc | Differentiering af humane embryonale stamceller |
| AU2011223900A1 (en) | 2010-03-01 | 2012-09-13 | Janssen Biotech, Inc. | Methods for purifying cells derived from pluripotent stem cells |
| AU2011250912A1 (en) | 2010-05-12 | 2012-11-22 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| WO2012030540A2 (en) | 2010-08-31 | 2012-03-08 | Janssen Biotech, Inc. | Differentiation of pluripotent stem cells |
| CN103221536B (zh) | 2010-08-31 | 2016-08-31 | 詹森生物科技公司 | 人胚胎干细胞的分化 |
| KR101836850B1 (ko) | 2010-08-31 | 2018-03-09 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
| US9248120B2 (en) | 2011-08-23 | 2016-02-02 | The Board Of Trustees Of The Leland Stanford Junior University | Reversing intestinal inflammation by inhibiting retinoic acid metabolism |
| RU2705001C2 (ru) | 2011-12-22 | 2019-11-01 | Янссен Байотек, Инк. | Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки |
| MX354775B (es) | 2012-03-07 | 2018-03-20 | Janssen Biotech Inc | Medios definidos para la expansion y el mantenimiento de celulas madre pluripotentes. |
| CN104334719B (zh) | 2012-06-08 | 2018-02-13 | 詹森生物科技公司 | 人胚胎干细胞向胰腺内分泌细胞的分化 |
| MX2015008578A (es) | 2012-12-31 | 2015-09-07 | Janssen Biotech Inc | Diferenciacion de celulas madre embrionarias humanas en celulas endocrinas pancreaticas mediante el uso de relugadores de hb9. |
| DK2938722T3 (da) | 2012-12-31 | 2022-02-14 | Janssen Biotech Inc | Suspension og klyngedannelse af humane pluripotente celler til differentiering til endokrine pankreasceller |
| US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
| KR102084561B1 (ko) | 2012-12-31 | 2020-03-04 | 얀센 바이오테크 인코포레이티드 | 췌장 내분비 세포로의 분화를 위한 공기-액체 계면에서의 인간 배아 줄기세포의 배양 |
| SG11201609473XA (en) | 2014-05-16 | 2016-12-29 | Janssen Biotech Inc | Use of small molecules to enhance mafa expression in pancreatic endocrine cells |
| WO2017180361A1 (en) | 2016-04-14 | 2017-10-19 | Janssen Biotech, Inc. | Differentiation of pluripotent stem cells to intestinal midgut endoderm cells |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3404749B2 (ja) | 1996-06-27 | 2003-05-12 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｎ―［４―（ヘテロアリールメチル）フェニル］―ヘテロアリールアミン |
| AP869A (en) | 1998-01-05 | 2000-09-04 | Pfizer | 2,3-Substituted indole compounds as anti-inflammatory and analgesic agents. |
| CN1596240A (zh) * | 2001-12-19 | 2005-03-16 | 阿特罗吉尼克斯公司 | 查耳酮衍生物及其治疗疾病的用途 |
| US20060205945A1 (en) * | 2004-05-14 | 2006-09-14 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| PL372356A1 (pl) * | 2005-01-20 | 2006-07-24 | ADAMED Sp.z o.o. | Nowe związki, pochodne kwasu 3-fenylopropionowego |
| TW200639163A (en) * | 2005-02-04 | 2006-11-16 | Genentech Inc | RAF inhibitor compounds and methods |
-
2007
- 2007-10-17 CN CN2007800387031A patent/CN101611016B/zh not_active Expired - Fee Related
- 2007-10-17 US US12/311,862 patent/US8188124B2/en not_active Expired - Fee Related
- 2007-10-17 WO PCT/US2007/081685 patent/WO2008049027A1/en not_active Ceased
- 2007-10-17 CA CA2667053A patent/CA2667053C/en not_active Expired - Fee Related
- 2007-10-17 BR BRPI0718310-0A patent/BRPI0718310A2/pt not_active IP Right Cessation
- 2007-10-17 JP JP2009533511A patent/JP5343267B2/ja not_active Expired - Fee Related
- 2007-10-17 AU AU2007311026A patent/AU2007311026B2/en not_active Ceased
- 2007-10-17 EP EP07854136A patent/EP2114895A4/en not_active Withdrawn
- 2007-10-17 MX MX2009004096A patent/MX2009004096A/es active IP Right Grant
- 2007-10-17 KR KR1020097009986A patent/KR101419965B1/ko not_active Expired - Fee Related
-
2012
- 2012-05-21 US US13/476,216 patent/US8399495B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101611016B (zh) | 2012-01-25 |
| JP2010506953A (ja) | 2010-03-04 |
| US20120283204A1 (en) | 2012-11-08 |
| CA2667053C (en) | 2015-04-28 |
| EP2114895A4 (en) | 2011-06-22 |
| WO2008049027A1 (en) | 2008-04-24 |
| EP2114895A1 (en) | 2009-11-11 |
| US20100292284A1 (en) | 2010-11-18 |
| KR20090068286A (ko) | 2009-06-25 |
| AU2007311026B2 (en) | 2012-05-17 |
| KR101419965B1 (ko) | 2014-07-16 |
| US8188124B2 (en) | 2012-05-29 |
| AU2007311026A1 (en) | 2008-04-24 |
| JP5343267B2 (ja) | 2013-11-13 |
| CA2667053A1 (en) | 2008-04-24 |
| US8399495B2 (en) | 2013-03-19 |
| CN101611016A (zh) | 2009-12-23 |
| BRPI0718310A2 (pt) | 2013-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200728307A (en) | Novel spirochromanone derivatives | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| WO2007135527A3 (en) | Benzimidazolyl compounds | |
| WO2007117465A3 (en) | Indazole compounds | |
| WO2007084728A3 (en) | 2-imino-benzimidazoles | |
| TW200833675A (en) | Nicotinamide derivatives | |
| WO2010026436A3 (en) | 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders | |
| WO2009155121A3 (en) | Inhibitors of pi3 kinase | |
| UA94833C2 (en) | Substituted bicyclolactams | |
| EA200801998A1 (ru) | ПИРИДИН[3,4-b]ПИРАЗИНОНЫ | |
| WO2008012635A3 (en) | Amine derivatives useful as anticancer agents | |
| WO2008157751A3 (en) | Substituted imidazoheterocycles | |
| WO2009016410A3 (en) | Chemical compounds 831 | |
| WO2006011050A3 (en) | Pyridine derivatives | |
| MY145795A (en) | Pyrazoline compounds | |
| WO2009025785A3 (en) | Cb2 receptor ligands for the treatment of pain | |
| WO2005021544A3 (en) | N3-substituted imidazopyridine-derivatives as c-kit inhibitors | |
| PT1696905E (pt) | 2-aminotetralinas substituídas para o tratamento preventivo da doença de parkinson | |
| WO2010066629A3 (en) | Novel azaindoles | |
| MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
| MX2009012125A (es) | Compuestos terapeuticos. | |
| WO2006113552A3 (en) | Cyanoarylamines | |
| WO2007052123A3 (en) | Pyrazine derivatives as sodium channel modulators for the treatment of pain | |
| MX2009006010A (es) | Derivados de amina y su uso en enfermedades mediadas por el adrenoreceptor beta 2. | |
| MY148538A (en) | Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |